New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > CymaBay Therapeutics, Inc.
CymaBay Therapeutics, Inc.
Industry: Life Sciences ・ $CBAY on Nasdaq ・ Market Cap: Medium
CEO Sales
Top Executive Sales
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
| TRADES PURCHASE/SALE Sector Average | 0 / 15 2.19 / 7.65 |
| INSIDER BUYERS/SELLERS Sector Average | 0 / 5 1.2 / 2.5 |
| SHARES PURCHASED/SOLD Transaction Average | 0 / 242,302 0 / 16,153 |
| VALUE PURCHASED/SOLD Transaction Average | $0 / $4,825,560 $0 / $321,704 |
| PURCHASE RANGE | N/A |
| SALE RANGE | N/A |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
0 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
2 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
No Insider Trades made
0%
DIRECTORS
0%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | N/A 0.2 |
VALUE GINI INDEX Sector Average | N/A 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
53.77%
DIRECTORS
46.23%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.365 0.295 |
VALUE GINI INDEX Sector Average | 0.405 0.288 |
CymaBay Therapeutics, Inc. 1Y Trade Transactions
Submission Date Period of Report | Insider | Position | Total Value | Shares | Share Price | Ownership % Change | Shares Owned | Post Day Stock Change | Post Week Stock Change | |
|---|---|---|---|---|---|---|---|---|---|---|
2024-02-14 2024-02-12 | Dorling Janet | Director | -$191,820 | 6,000 | $31.97 | -100% | 0 | +0.23% | +0.20% | |
2024-01-22 2024-01-19 | McWherter Charles | Officer | -$435,599 | 18,403 | $23.67 | -55.09% | 15,000 | -2.88% | -1.04% | |
2024-01-16 2024-01-16 | Menold Daniel | Officer | -$235,800 | 10,000 | $23.58 | -100% | 0 | -0.91% | -3.84% | |
2024-01-16 2024-01-16 | Quinlan Paul T | Officer | -$117,900 | 5,000 | $23.58 | -100% | 0 | -0.91% | -3.84% | |
2024-01-10 2024-01-10 | Dorling Janet | Director | -$143,160 | 6,000 | $23.86 | -100% | 0 | +2.53% | +2.78% | |
2023-12-18 2023-12-18 | McWherter Charles | Officer | -$243,411 | 11,332 | $21.48 | -43.04% | 15,000 | 0.00% | +4.07% | |
2023-12-15 2023-12-15 | Menold Daniel | Officer | -$472,719 | 21,497 | $21.99 | -100% | 0 | +2.72% | +4.81% | |
2023-12-15 2023-12-15 | Quinlan Paul T | Officer | -$109,900 | 5,000 | $21.98 | -100% | 0 | +2.72% | +4.81% | |
2023-12-11 2023-12-11 | Shah Sujal | Director | -$1,323,246 | 64,865 | $20.4 | -27.47% | 171,301 | +3.07% | +10.18% | |
2023-12-11 2023-12-11 | Dorling Janet | Director | -$120,420 | 6,000 | $20.07 | -100% | 0 | +3.07% | +10.18% |